

CGeneTech (Suzhou, China) Co., Ltd. founded in Suzhou Industrial Park (SIP) in 2010, is dedicated to developing and commercializing innovative small molecule drugs for breakthrough therapies.
CGeneTech(Suzhou,China) Co., Ltd. is a biotechnology company in the commercialization stage, with its core product, Class 1 innovative drug Shenggliptin, on the market. The company was founded in Suzhou Industrial Park in 2010, with a core team with decades of experience in the entire lifecycle of international drugs, dedicated to the research and development and industrialization of high-quality and differentiated small molecule innovative drugs. With an integrated drug research and development technology platform and a diversified business perspective, the company has built a rich pipeline of innovative drugs covering hypoglycemic, anticancer, and autoimmune diseases.
Dedicated to the development, manufacture and marketing of small molecule innovative drugs
News
Company News | Media Reports
Cooperation
We want to build long-term business relationships with customers from all over the world on a mutually beneficial basis!
Contact Us
Tel: +86-512-62956960(Recruitment)
+86-512-62956961(marketing)
E-mail:hr@cgenetech.com.cn